HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel nPulse™ technology using its proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or ...
Pulse Biosciences Announces Clinical Data Highlighting its nPulse™ Cardiac Surgical System to be Presented at the 39th European Association for Cardio-Thoracic Surgery Annual Meeting Pulse Biosciences ...
NIBS may offer targeted therapeutic benefits for patients with ADHD, reducing inattention as well as hyperactivity and impulsivity symptoms. Noninvasive brain stimulation (NIBS) techniques may offer ...
Treasury Secretary Scott Bessent said Thursday U.S. farmers could see an announcement on a “substantial support” package as soon as Tuesday to deal with the fallout from the trade tensions with China.
Introduction: In recent years, non-invasive brain stimulation (NIBS) interventions for attention-deficit/hyperactivity disorder (ADHD) have received increasing ...
We recently compiled a list of the 12 Healthcare Stocks with Insider Buying in 2025. Pulse Biosciences, Inc. is one of them. Pulse Biosciences, Inc. (NASDAQ:PLSE) is advancing bioelectric medicine ...
Background: Pulse dosing of high frequency spinal cord stimulation at 10 kHz (10 kHz SCS) may offer comparable clinical benefits as continuous 10 kHz SCS, but extreme pulse dosing (EPD) has not been ...
The Agriculture Department's shutdown plan calls for furloughing more than 42,000 employees, or nearly half its current workforce. With lawmakers in a partisan stalemate over funding the government in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback